Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-06 @ 6:44 AM
Study NCT ID:
NCT00096993
Status:
COMPLETED
Last Update Posted:
2015-06-10
First Post:
2004-11-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-17
First Submit QC Date:
None
Study First Post Date:
2004-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-26
Results First Submit QC Date:
None
Results First Post Date:
2015-06-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-08
Last Update Post Date:
2015-06-10
Last Update Post Date Type:
ESTIMATED